Registered Tanzania · TMDA

Hyfresh

Sodium Hyaluronate 2 mg/ml

TZ 16 H 0085 Ophthalmic Solution 2 dermatologicals INN generic

What it does

Hyaluronate is a substance that helps to keep tissues in the body hydrated and lubricated.

Commonly used for: joint pain, osteoarthritis, eye conditions (like dry eyes)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TZ 16 H 0085
Registration date
2026-02-27
Expiry date
2031-02-26
Status
Registered/Compliant
Active ingredient
Sodium Hyaluronate 2 mg/ml
Dosage form
Ophthalmic Solution
Strength
2
Pack size
-
Therapeutic class
-
ATC class (WHO)
D03AX - Other cicatrizants
Drug group
DERMATOLOGICALS
RxNorm RxCUI
62372
Manufacturer / MAH
Jamjoom Pharmaceuticals
Country of origin
KINGDOM OF SAUDI ARABIA
Manufacturer location
Jeddah 1st Industrial City, Jeddah 21442, Saudi Arabia

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-04-30 08:11:03 · updated 2026-09-14 03:00:45

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Hyaluronate is a substance that helps to keep tissues in the body hydrated and lubricated.

What it treats

  • joint pain
  • osteoarthritis
  • eye conditions (like dry eyes)

How it works

Hyaluronate acts by attracting water, which helps to cushion and lubricate joints and tissues.

Who it's for

It is used for people with joint pain or certain eye conditions, particularly in older adults.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: hyaluronate

Hyaluronate, also known as hyaluronic acid, is a naturally occurring glycosaminoglycan (GAG) that is a crucial component of connective tissues. It is widely used in various medical fields, including orthopedics, dermatology, and ophthalmology, due to its ability to retain water and provide lubrication. In joint health, hyaluronate is utilized as a viscosupplement to relieve pain in osteoarthritis, particularly in the knee. It is also employed in ocular surgeries and for the treatment of dry eyes.

Indications

  • Osteoarthritis of the knee
  • Viscosupplementation for joint pain
  • Dry eye syndrome
  • Ocular surgeries (e.g., cataract surgery)
  • Wound healing

Dosage

Adults: Refer to specific guidelines or literature for adult dosing recommendations, as they can vary based on

Mechanism of action

Hyaluronate acts by increasing the viscosity and elasticity of synovial fluid in joints, leading to improved lubrication and shock absorption. It binds to water molecules, thus enhancing the hydration of tissues. In the context of osteoarthritis, it helps to restore the normal viscoelastic properties of the joint fluid, which can help alleviate pain and improve joint function. In ocular applications, it serves to lubricate the surface of the eye, aiding in the comfort and healing of the cornea.

Pharmacodynamics

Hyaluronate's pharmacodynamic effects are primarily related to its hydrophilic nature and its ability to form a gel-like consistency when mixed with water. This property allows it to provide mechanical support and cushioning in joints, reducing friction and wear in the articular cartilage. It also plays a role in cell signaling and tissue hydration, influencing cell proliferation and migration in wound healing.

Pharmacokinetics

Hyaluronate is administered via injection or topical application, depending on the indication. After injection into the joint space, it can remain for several weeks, but its half-life is influenced by factors such as the degree of synovial fluid viscosity and the presence of inflammation. Systemic absorption is minimal, and it is primarily metabolized by hyaluronidase enzymes found in various tissues, leading to fragmentation and clearance from the body. In ocular formulations, its retention time on the eye surface can vary based on the formulation and the presence of preservatives.

Contra-indications

  • Hypersensitivity to hyaluronate or any component of the formulation
  • Infection at the injection site
  • Active skin diseases

Adverse effects

  • Injection site reactions (pain, swelling, redness)
  • Allergic reactions
  • Joint effusion
  • Increased joint pain
  • Headache

Precautions

  • Use with caution in patients with bleeding disorders
  • Careful consideration in patients with a history of allergic reactions
  • Not recommended for intra-articular injection in patients with active infections

Pregnancy

Safety in pregnancy has not been established. Use only if clearly needed and the potential benefits justify the risks.

Breast-feeding

It is not known if hyaluronate is excreted in human milk. Use with caution and only if clearly needed.

Storage

Store at 2-25 degrees Celsius. Protect from light. Do not freeze.

Formulations

  • Sodium hyaluronate injection
  • Hyaluronic acid gel

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.